Charlie Huiner, MBA

President and CEO | Modulim

Charlie brings over 25 years of executive experience with a successful leadership track record in healthcare across multiple markets including biotech, medical devices, and digital health. He is accomplished at developing and executing corporate growth strategies, securing financing, and building high-performing teams. Prior to joining Modulim, Charlie was the Chief Operating Officer and Senior VP, Corporate Development and Strategy for Sientra, Inc. (NASDAQ: SIEN), a global medical aesthetics company. During his tenure there, Charlie authored the Company’s growth strategy, led several transformative acquisitions, and helped raise $375 million in equity financing including a successful IPO. Prior to that, he was Vice President of Marketing and Business Development at InTouch Health during a transformative period that solidified the Company’s market strategy and commercial model ahead of its eventual exit to Teladoc Health. He received his B.A. from Williams College, an M.B.A. in Finance and Marketing from Northwestern University’s Kellogg School, and currently serves as an independent board member of Recros Medica. 

David J. Cuccia, Ph.D.

Founder & CTO | Modulim

An internationally recognized pioneer and leader in spatial frequency domain imaging (SFDI), David secured over $11 million in SBIR/STTR grants that facilitated the development of Modulim’s technology. He has nine patents with two more pending. His contributions to science include over 100 co-authored publications and more than 4000 citations in biomedical optics. David earned a B.S in Physics and a Ph.D. in Biomedical Engineering from the University of California, Irvine. 

Janelle Goulard, M.B.A.

Partner, Health Investment | Pangaea Ventures

Janelle has over 12 years’ healthcare experience working in private investments, scaling ventures, and management consulting. She has spent a large part of her career at GE Healthcare, in the US and Europe, working with both private and public health organizations. Janelle’s entrepreneurial endeavors include launching a population health technology platform that became a joint venture between GE and Microsoft. Janelle has an M.B.A. from the University of British Columbia and a Bachelor of Commerce degree (B. Com) from McGill University.

Francis Duhay, M.D., M.B.A.

Founder & CEO | Koa Accel

An accomplished clinical surgeon, scientist, medical innovator, and senior business executive, Francis has expertise in general management, clinical and regulatory affairs, and healthcare economics. Double board-certified in general and cardiothoracic surgery, he has served as senior faculty at the Duke University School of Medicine and was formerly Chief Medical Officer for Edwards Life Sciences. With 32 US and international patents, Francis has invented, and developed devices used in thousands of heart operations each year.

Keith Bennett, Ph.D.

Keith works with established and start-up companies to identify and create new business opportunities, with an emphasis on photonic technologies. Current and past clients include Hamamatsu Photonics, Ricoh, NTT Labs, the Japanese Science and Technology Agency, KLA-Tenco, and several smaller firms. Prior to establishing his consulting practice, Keith worked in product management for Newport Corporation (now MKS) and Park Scientific Instruments (now Bruker), and co-founded Symphony Systems (now Pivotal Systems), a pioneering company in a field now termed “the internet of things.” He has degrees from M.I.T. (Physics, B.S.) and Stanford University (Applied Physics, M.S., and Ph.D.), and over 10 issued patents.

Randy Lunn

Managing Director | Catalina Ventures

With over 30 years of early-stage capital experience, Randy has a proven track record of finding, financing, and supporting entrepreneurs. He is currently Managing Director of Catalina Ventures, a firm that focuses on early-stage companies in technology, life sciences, and other advanced technologies. Randy began his venture career in 1979 as a founder of Harrison Capital, the venture arm of Texaco. Since then, funds he has founded and managed have raised over $1 billion from institutional sources.

Wilson Constantine

President | Americas Region Smiths Medical

Wilson is an accomplished executive in the medical device industry with over two decades of experience in transforming companies to deliver growth and maximize shareholder value. He is currently the President of the Americas Region at Smiths Medical, a global provider of medical devices and technologies to hospitals and the alternate care market. Previously, he was President of Nihon Kohden America where he transitioned the company to a multimillion-dollar, multichannel leader with the fastest growth in the market. Prior to that, Wilson was the CEO of Monarch Medical Technologies, a private equity-backed spinout of Hospira worldwide. He also served in executive leadership roles at Stryker Orthopaedics and Henry Schein, Inc. as well as other leading medical product suppliers, including units of and/or entities later acquired by Aesculap-B/Braun, Boston scientific, Medtronic and Smith & Nephew.